Trial intelligence / Profile preview

Corticosteroid in treatment of acute laryngitis among vocal professionals

2021-006497-23Phase 4Active

Sponsor
Helsinki University Hospital
Start
Jan 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of prednisolone in Acute Laryngitis, sponsored by Helsinki University Hospital. Primary endpoint: Primary: Resolution of laryngitis. Started Jan 2022; status: active.

02

Drugs

prednisolone
03

Conditions

Acute Laryngitis

Beyond the preview

Go deeper on 2021-006497-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-006497-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call